Syra Health (Syra Health) Interest Expense : $-0.05 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Syra Health Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Syra Health's interest expense for the three months ended in Mar. 2024 was $ -0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.05 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Syra Health's Operating Income for the three months ended in Mar. 2024 was $ -1.41 Mil. Syra Health's Interest Expense for the three months ended in Mar. 2024 was $ -0.00 Mil. Syra Health did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Syra Health Interest Expense Historical Data

The historical data trend for Syra Health's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syra Health Interest Expense Chart

Syra Health Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Interest Expense

-0.03

-0.05

Syra Health Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial					-0.01	-0.02	-0.01	-0.01	-

Syra Health Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.05 Mil.

Syra Health (NAS:SYRA) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Syra Health's Interest Expense for the three months ended in Mar. 2024 was $-0.00 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-1.41 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $0.00 Mil.

Syra Health's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Syra Health did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Syra Health (Syra Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Syra Health Corp (NAS:SYRA) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1119 Keystone Way North, No. 201, Carmel, IN, USA, 46032

Website

https://www.syrahealth.com

Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health. The Company has two main forms of revenue - healthcare staffing revenue and medical communication revenue. The majority of revenue is derived from healthcare staffing.

Executives

Sandeep Allam	director, officer: President and Chair	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Feroz Syed	10 percent owner	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Deepika Vuppalanchi	director, officer: Chief Executive Officer	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Vijayapal Reddy	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Avutu Reddy	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Ketan Paranjape	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Andrew Dahlem	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Sherron Rogers	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Joe D Thomas	10 percent owner	2046 EAST MURRAY-HOLIDAY ROAD, SALT LAKE CITY UT 84117
Sls Group Llc	10 percent owner	6582 S BIG COTTONWOOD CANYON RD. #200, SALT LAKE CITY UT 84121
Priya Prasad	officer: CFO and COO	1119 KEYSTONE WAY N., #201, CARMEL IN 46032